New drug combo tested for weight control
NCT ID NCT06345066
Summary
This study tested the safety of combining two weight management drugs, tirzepatide and a new drug called LY3841136, in overweight and obese adults. It involved 96 participants and lasted about 42 weeks. The main goal was to see if the combination was safe and well-tolerated, while also checking for changes in body weight.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit
Daytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit
Dallas, Texas, 75247, United States
-
Fortrea Clinical Research Unit
Madison, Wisconsin, 53704, United States
Conditions
Explore the condition pages connected to this study.